Journal article
C. Parra, L. Castillo‐Pichardo, L. Cubano, G. Calin, S. Dharmawardhane
2013
2013
Semantic Scholar
DOI
Cite
Cite
APA
Click to copy
Parra, C., Castillo‐Pichardo, L., Cubano, L., Calin, G., & Dharmawardhane, S. (2013). Abstract A057: Therapeutic potential of genistein via targeting the microRNA miR-155 in breast cancer.
Chicago/Turabian
Click to copy
Parra, C., L. Castillo‐Pichardo, L. Cubano, G. Calin, and S. Dharmawardhane. “Abstract A057: Therapeutic Potential of Genistein via Targeting the MicroRNA MiR-155 in Breast Cancer” (2013).
MLA
Click to copy
Parra, C., et al. Abstract A057: Therapeutic Potential of Genistein via Targeting the MicroRNA MiR-155 in Breast Cancer. 2013.
BibTeX Click to copy
@article{c2013a,
title = {Abstract A057: Therapeutic potential of genistein via targeting the microRNA miR-155 in breast cancer},
year = {2013},
author = {Parra, C. and Castillo‐Pichardo, L. and Cubano, L. and Calin, G. and Dharmawardhane, S.}
}
Abstract
We previously reported that dietary genistein significantly inhibits mammary tumor growth and metastasis of estrogen receptor (ER) (-) MDA-MB-435 metastatic cancer cells in immunocompromised mice. The purpose of the present study is to investigate the molecular mechanisms of genistein in ER (-) breast cancer cells. We report that at low physiologically relevant concentrations, genistein significantly inhibits cell growth and induces apoptosis in MDA-MB-435 and Hs578t breast cancer cells. To investigate the mechanism by which genistein regulates cancer cell viability, a panel of microRNAs (miRNAs) were tested for differential expression in response to genistein treatment. We found that miR-155, a designated oncomiR in breast cancer, is significantly downregulated by genistein in MDA-MB-435 and Hs578t cells. Concomitantly, pro-apoptotic and anti-cell proliferative miR-155 targets FOXO3, PTEN, casein kinase (CK1alpha), and p27 are upregulated by genistein. Moreover, the CK1alpha target beta catenin is downregulated in the MDA-MB-435 cells, thus further contributing to the anticancer effects of genistein by inhibiting wnt signaling. Stable ectopic expression of miR-155 in MDA-MB-435 and Hs578t cells decreases the inhibitory effect of genistein on cell viability, and abrogates the effect of genistein on apoptosis and expression of pro-apoptotic proteins. Therefore, genistein acts as a potential anti breast cancer therapeutic via downregulation of miR-155, a critical suppressor of apoptosis. This study was sponsored by United States Army/BCRP W81XWH-11-1-0199 (to CDP), NIH/NIGMS SC3GM084824 (to SD), NIH/NIGMS G12RR035051 (to UPR MSC), and NIH/NIGMS G12RR003035 and Title V PPOHA US Department of Education #P031M105050 (to UCC). Citation Format: Columba de la Parra, Linette Castillo-Pichardo, Luis A. Cubano, George A. Calin, Suranganie Dharmawardhane. Therapeutic potential of genistein via targeting the microRNA miR-155 in breast cancer. [abstract]. In: Proceedings of the AACR Special Conference on Advances in Breast Cancer Research: Genetics, Biology, and Clinical Applications; Oct 3-6, 2013; San Diego, CA. Philadelphia (PA): AACR; Mol Cancer Res 2013;11(10 Suppl):Abstract nr A057.
